The overall objectives of the Clinical Research Core (CRC) over the next 5 years are to promote and support clinical HIV research in the Pacific Northwest region through: 1) Recruitment and referral of HIV-infected persons into clinical research protocols to increase the productivity of these funded studies, 2) Expansion of the UW HIV Specimen Repository to support translational clinical and pathogenesis research and 3) Expansion of the Study Assistance and Specimen Collection Service to aid investigators in the enrollment and implementation of their HIV research protocols Recruitment and referral of potential research subjects will be performed by a dedicated research referral nurse who screens all UW Registry patients cared for at the UW HIV clinics, identifies eligible patients based on study criteria and refers patients to study coordinators for enrollment. Expansion of the UW HIV Specimen Repository will be accomplished by continued, targeted enrollment of HIV+ subjects at the UW HIV clinics and linkage to other research groups such as the CFAR Network of Integrated Systems (C-NICS) and the Kampala HIV discordant couples study. Increased utilization of the Repository will continue due to enhanced CRC advertising efforts and since the Repository has now reached a size sufficient to accommodate investigator requests. Expansion of the Study Assist and Specimen Collection Service will be possible due to the increased expertise of CRC staff, the availability of space (examination room) and resources (office equipment, freezers, liquid nitrogen tanks) and the enhanced advertisement of these services to regional investigators. These activities will tightly link the CRC to the Clinical Epidemiology and Health Services Research, Clinical Retrovirology, Developmental, International and Sociobehavioral and Prevention Cores, all the UW CFAR Institutions (Fred Hutchinson Cancer Center, Seattle Biomedical Research Institute, UW School of Medicine, Children's Hospital and Regional Medical Center) and other local and national research groups. These strategies serve to augment existing funded research programs that depend on successful accrual of patients and access to patient specimens. This value-added approach directly supports the large, diverse HIV research programs that exist at the University of Washington, and provides ready access to HIV infected patients, patient specimens and the clinical resources needed to implement clinical studies. These efforts advance the clinical HIV research agendas of local and national HIV investigators and contribute to the fight against HIV and AIDS by providing researchers with the clinical resources needed to conduct their investigations. These resources include access to potential research subjects, patient specimens (such as blood components) and the space and tools needed to perform their research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-25
Application #
8376314
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
25
Fiscal Year
2012
Total Cost
$336,874
Indirect Cost
$120,929
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Young, J; Smith, C; Teira, R et al. (2018) Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection. HIV Med 19:132-142
Olwit, Connie; Mugaba, Maureen; Osingada, Charles Peter et al. (2018) Existence, triggers, and coping with chronic sorrow: a qualitative study of caretakers of children with sickle cell disease in a National Referral Hospital in Kampala, Uganda. BMC Psychol 6:50
Torres, Thiago S; Harrison, Linda J; La Rosa, Alberto M et al. (2018) Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings. AIDS Care 30:954-962
Heffron, Renee; Mugo, Nelly; Hong, Ting et al. (2018) Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention. AIDS 32:1707-1713
Pyra, Maria; Brown, Elizabeth R; Haberer, Jessica E et al. (2018) Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships. AIDS Behav :
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Edwards, Jessie K; Cole, Stephen R; Moore, Richard D et al. (2018) Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula. Am J Epidemiol :
LaCourse, Sylvia M; Cranmer, Lisa M; Bekker, Adrie et al. (2018) Symptom screening for active tuberculosis in pregnant women living with HIV. Cochrane Database Syst Rev 2018:
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Wagner, Anjuli D; O?Malley, Gabrielle; Firdawsi, Olivia et al. (2018) Brief Report: Disclosure, Consent, Opportunity Costs, and Inaccurate Risk Assessment Deter Pediatric HIV Testing: A Mixed-Methods Study. J Acquir Immune Defic Syndr 77:393-399

Showing the most recent 10 out of 1275 publications